Nondisclosure of Complementary and Alternative Medicine Use to Primary Care Physicians

Jou, Judy; Johnson, Pamela Jo

doi:10.1001/jamainternmed.2015.8593

Cited by 104 publications

(96 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is particularly salient when discussing DI-AIH, given that 23% of patients with AIH are >60 years of age 20. Because a lack of physician inquiry or knowledge about CAM use is a reason frequently cited by US adults for non-disclosed use of NVNM DS or other CAM modalities,7 greater vigilance on the part of healthcare providers is needed, particularly when caring for at-risk populations with a high prevalence of NVNM use.…”

Section: Discussionmentioning

confidence: 99%

Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use

et al. 2018

View full text Add to dashboard Cite

Turmeric dietary supplement sales, which accounted for US$69 million in spending in 2016, have been increasing exponentially in the USA, making this one of the most popular botanical supplements sold in the USA. Herbal supplement use, which is generally regarded as safe by consumers, is not usually reported to healthcare providers. We reported here on a case of autoimmune hepatitis, occurring in a 71-year-old woman taking turmeric dietary supplements for the maintenance of cardiovascular health, which resolved rapidly following discontinuation of the turmeric supplements. Of particular note, turmeric use was not documented in the patient's medical records and the potential causative role of the turmeric supplementation was ultimately identified by the patient rather than the healthcare providers. To our knowledge, this is the first documented report of turmeric supplement-induced autoimmune hepatitis.

show abstract

Section: Discussionmentioning

confidence: 99%

Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Therefore, in this study it is unknown whether disclosure was patient initiated or provider initiated, or how positive CHA experiences and beliefs about CHA may be related to each type of disclosure. Indeed, there is evidence that CHA use is not likely to be disclosed if the provider doesn’t initiate the discussion (22). Accordingly, future work on CHA disclosure behaviour should take a more fine-grained approach to assessing the circumstances surrounding CHA disclosure, and employ a longitudinal approach to test the temporal precedence of CHA values in relation to disclosure suggested by the CAM consumer commitment model (30).…”

Section: Discussionmentioning

confidence: 99%

“…Understanding the factors that can facilitate disclosure of CHA use can help to guide educational strategies for both CHA users and conventional health-care providers, as well as inform clinical guideline practices. Yet to date, the research on CHA disclosure has been largely atheoretical and focused on barriers to disclosure, such as poor patient-provider communication (17, 20–22), rather than on factors that might promote or facilitate disclosure of CHA use, such as beliefs and outcomes from CHA use. The aim of this study was to address this gap by applying recent theoretical developments on CHA-related behaviours to understand the implicit reasons for disclosure of CHA use using a large, nationally representative sample.…”

mentioning

confidence: 99%

Implicit Reasons for Disclosure of the Use of Complementary Health Approaches (CHA): a Consumer Commitment Perspective

2017

View full text Add to dashboard Cite

Background Disclosure of the use of complementary health approaches (CHA) is an important yet understudied health behaviour with important implications for patient care. Yet research into disclosure of CHA has been atheoretical and neglected the role of health beliefs. Purpose Using a consumer commitment model of CHA use as a guiding conceptual framework, the current study tests the hypotheses that perceived positive CHA outcomes (utilitarian values) and positive CHA beliefs (symbolic values) are associated with disclosure of CHA to conventional-care providers in a nationally representative US sample. Methods From a sample of 33,594 with CHA use information from the 2012 National Health Interview Survey (NHIS), a subsample of 7,348 who used CHA within the past 12 months was analysed. The 2012 NHIS is a cross-sectional survey of the non-institutionalized US adult population, which includes the most recent nationally representative CHA use data. Results The 63.2 % who disclosed CHA use were older, less educated, and had visited a health-care provider in the past year. Weighted logistic regression analyses controlling for demographic variables revealed that those who disclosed were more likely to report experiencing positive psychological (improved coping and well-being) and physical outcomes (better sleep, improved health) from CHA, and hold positive CHA-related beliefs. Conclusions CHA users who perceive physical and psychological benefits from CHA use, and who hold positive attitudes towards CHA are more likely to disclose their CHA use. Findings support the relevance of a consumer commitment perspective for understanding CHA disclosure, and suggest CHA disclosure as an important proactive health behaviour that warrants further attention.

show abstract

“…The rate of nondisclosure obtained in this study is comparable to the results of previous reports in the literature which showed that a significant proportion of PLWHA are reluctant to discuss their use of CAM with the physician (53% in Ontario, Canada [15]; 68% in Malaysia [27]). Potential reasons for not discussing the CAM use with the physician could be related to physicians not asking about CAM use or to concerns about physician knowledge regarding CAM rather than to physician discouragement or negativity about the use of CAM [64]. Additional reasons may include patients' concerns for disproval and loss of medical care privileges, in addition to the belief that CAM is safe, holistic, natural, and nontoxic in contrast to conventional medicine, which is usually perceived as depersonalized and not completely effective [65].…”

Section: Discussionmentioning

confidence: 99%

Prevalence and Characteristics of CAM Use among People Living with HIV and AIDS in Lebanon: Implications for Patient Care

Abou-Rizk

Alameddine

Naja

2016

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

This study aimed to assess the prevalence and determinants of Complementary and Alternative Medicine (CAM) use among People Living with HIV and AIDS (PLWHA) in Lebanon and to identify related issues that may affect patient care. A cross-sectional survey design was used to interview 116 PLWHA in Beirut. The questionnaire addressed sociodemographic and disease characteristics as well as CAM use. The main outcome of the study was CAM use since diagnosis. Data analysis included descriptive statistics and logistic regression analyses. Overall, 46.6% of participants reported using one or more CAM therapies, with herbs and herbal products being the most commonly used (63%). A higher education level was associated with a 3-fold increase in the odds of CAM use. Among users, 20% used CAM as alternative to conventional treatment, 48% were not aware of CAM-drug interactions, 89% relied on nonhealth care sources for their choice of CAM, and 44% did not disclose CAM use to their physician. CAM use is prevalent among Lebanese PLWHA. Findings of this study highlighted the need to educate health care practitioners to have an open communication and a patient-centered approach discussing CAM use during routine care and to enhance awareness of PLWHA on safe use of CAM.

show abstract

Nondisclosure of Complementary and Alternative Medicine Use to Primary Care Physicians

Cited by 104 publications

References 4 publications

Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use

Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use

Implicit Reasons for Disclosure of the Use of Complementary Health Approaches (CHA): a Consumer Commitment Perspective

Prevalence and Characteristics of CAM Use among People Living with HIV and AIDS in Lebanon: Implications for Patient Care

Contact Info

Product

Resources

About